Figure 1.

Schematic of the strategy for personalized treatment of liposarcoma patients.

Blood samples and tumor tissues were obtained from patients for primary cell culture, and a patient-derived tumor xenograft mice model was established. Isolated patient-derived tumor cells and tissues were analyzed using histology and genomic profiling, and used for drug screening.